C. Radunsky et al. / Inorganica Chimica Acta 428 (2015) 14–20
15
2.2. Ligands and complexes
(calcd. 66.0), H 5.8 (calcd. 6.0), N 27.9 (28.0) %. ESI-MS: m/
z = 201.1136 ([M+H]+ = 201.1140). IR (KBr):
m
(C@N) 1598 (vs)
~
The synthesis of the hydrazone-based compounds 3–5 has been
reported previously [7]. Compounds H6 and H7 have been synthe-
sized analogously. In the key step of this synthesis, a solution of
compound 1 (or 2) [11] in ethanol was treated with an equimolar
amount of the respective aldehyde (ketone) and acetic acid as a
catalyst. The reaction mixture was stirred for 1 h at 58 °C. The reac-
tion volume was reduced to the half, water was added and the
respective product crystallized at ꢀ26 °C overnight. Filtration and
drying at 40 °C led to the respective clean product in 54ꢀ74% yield.
Non-methylated analogues of H6 and H7 have been reported pre-
viously by other groups and are not subject of this study [12,13].
Metal complexes were obtained by the addition of a methanolic
solution of the respective ligand to a methanolic solution of an
equimolar amount of metal salt or precursor complex (Co(NO3)2ꢁ
6H2O, Cr(NO3)3ꢁ9H2O, CuCl2ꢁ2H2O, FeSO4, MnCl2ꢁ4H2O, [PdCl2
(cod)], NiCl2ꢁ6H2O, CuI, NiSO4ꢁ6H2O, ZnCl2). Stirring for 1–3 h at
ambient temperature led to the product as an amorphous solid,
which was purified by filtration and washing with a methanol/
Et2O mixture. The respective pure product was isolated after dry-
ing at 40 °C overnight in 70ꢀ92% yield. During the investigation
of the chromogenic behaviour, Pd(OAc)2 in CH3CN was used
instead of [PdCl2(cod)] because of better solubility.
cmꢀ1
.
Complex [Pd(1)Cl2]: 1H NMR (DMSO-d6): d = 8.67 (s, 2H, NH2),
8.31 (dd, 1H, H4), 7.82 (m, 1H, H6), 6.83 (dd, 1H, H5), 6.78 (d,
1H, H3), 3.14 (s, 3H, CH3) ppm. 13C NMR (DMSO-d6): d = 160.2
(C2), 145.6 (C4), 140.5 (C6), 114.0 (C5), 107.8 (C3), 38.0 (CH3)
ppm. C6H9Cl2N3Pdꢁ0.25CH3OH: C 24.6 (calcd. 24.3), H 3.3 (calcd.
3.3), N 13.9 (calcd. 13.6)%. ESI-MS: m/z = 228.9825 ([M–2Cl]+):
228.9831.
Complex [Pd(1)2]Cl2ꢁ3H2O: 1H NMR (D2O/DMSO-d6): d = 8.05 (dd,
2H, H4), 7.72 (d, 2H, H6), 7.04 (dd, 2H, H5), 6.98 (d, 2H, H3), 3.48 (s,
6H, CH3) ppm. 13C NMR (D2O/DMSO-d6): d = 162.0 (C2), 147.9 (C4),
143.6 (C6), 117.1 (C5), 110.3 (C3), 39.9 (CH3). C12H24Cl2N6O3Pd: C
30.6 (calcd. 30.2), H 4.7 (calcd. 5.1), N 17.7 (calcd. 17.6)%. ESI-
MS: m/z = 176.0305 ([Pd(1)2]2+: 176.0314).
Complex [Cu(1)Cl2]: C6H9Cl2CuN3: C 28.0 (calcd. 28.0), H 3.4
(calcd. 3.5),
N 16.2 (calcd. 16.3)%. ESI-MS: m/z = 220.9774
([MꢀCl]+: 220.9781).
Complex [Cu(3)Cl2]: C12H12Cl2CuN4: C 41.5 (calcd. 41.6), H 3.4
(calcd. 3.5),
N
16.2 (calcd. 16.2)%. ESI-MS: mꢀ/z1 = 310.0040
+
~
m
([MꢀCl] : 310.0047). IR (KBr):
(C@N) 1621 (vs) cm
.
Complex [Mn(3)Cl2(OH2)]: C12H14Cl2MnN4O: C 40.9 (calcd. 40.5),
H 3.8 (calcd. 4.0), N 15.9 (calcd. 15.7)%. ESI-MSꢀ: 1m/z = 354.9920
+
Ligand H6: 1H NMR (CDCl3): d = 11.39 (s, 1H, OH), 8.25 (dd, 1H,
H60), 7.78 (s, 1H, CH@N), 7.58 (dd, 1H, H300), 7.30 (dd, 1H, H40),
6.91–6.85 (m, 3H, H400, H30, H500), 6.82 (dd, 1H, H50), 3.93 (s, 3H,
([M] ): 354.9925. IR (KBr):
(C@N) 1615 (vs) cm
.
~
m
Complex [Zn(3)Cl2]: 1H NMR (DMSO-d6): d = 11.78 (s, 1H, NH),
8.67 (m, 1H, H40), 8.19 (m, 2H, H600, H400), 8.06 (d, 1H, H60), 7.92
(dd, 1H, H500), 7.73 (m, 1H, H30), 7.16 (m, 2H, H50, H300), 2.59 (s,
13
OCH3), 3.68 (s, 3H, NCH3) ppm. C NMR (CDCl3): d = 156.5 (C20),
13
148.2 (C200), 147.3 (C60), 146.3 (C600), 138.1 (C300), 137.7 (CH@N),
121.6 (C400), 119.4 (C100), 119.0 (C500), 116.2 (C50), 111.9 (C30),
108.6 (C40), 56.0 (OCH3), 29.1 (NCH3) ppm. C14H15N3O2: C 65.4
(calcd. 65.4), H 5.8 (calcd. 5.9), N 16.4 (calcd. 16.3) %. ESI-MS: m/
~
3H, CH3) ppm. C NMR (DMSO-d6): d = 162.9 (C200), 152.1 (C20),
145.7 (C40), 142.0 (C400), 135.5 (C600, C60), 115.3 (H3CC@N), 52.4
(C300, C500), 31.2 (C50), 25.0 (C30), 4.9 (CH3) ppm. C12H12Cl2N4
Znꢁ0.5H2O: C 40.4 (calcd. 40.3), H 3.3 (calcd. 3.7), N 15.7 (calcd.
~
z = 258.1236 ([M+H]+ = 258.1243). IR (KBr):
m
(C@N) 1589 (vs)
15.7)%. ESI-MS: m/z = 311.0037 ([MꢀCl]+: 311.0042). IR (KBr):
m
cmꢀ1
.
(C@N) 1599 (vs) cmꢀ1
.
Ligand H7: 1H NMR (CDCl3): d = 9.01 (s, 1H, NH), 8.20 (ddd, 1H,
H60), 7.59 (s, 1H, CH@N), 7.55 (m, 2H, H50, H40), 6.86 (dd, 1H, H500),
6.73 (ddd, 1H, H30), 6.38 (ddd, 1H, H300), 6.26 (dd, 1H, H400), 3.62 (s,
Complex [Cu(4)Cl2]: C11H11Cl2CuN3Oꢁ0.33H2O: C 38.8 (calcd.
38.7), H 3.2 (calcd. 3.4),
N
12.3 (calcd. 12.3)%. ESI-MS: m/
z = 298.9880 ([MꢀCl]+: 298.9887). IR (KBr):
m
(C@N) 1612 (vs)
~
13
3H, CH3) ppm. C NMR (CDCl3): d = 157.6 (C20), 147.0 (C60), 137.3
cmꢀ1
.
(C200), 129.7 (CH@N), 127.0 (C40), 119.6 (C500), 114.9 (C300), 110.6
Complex [Pd(4)Cl2]ꢁ2H2O: 1H NMR (DMSO-d6): d = 8.56 (d, 1H,
H60), 8.37 (s, 1H, CH@N), 8.29 (m, 1H, H40), 8.11 (dd, 1H, H50),
(C500), 109.7 (C400), 109.3 (C30), 29.4 (CH3) ppm. C11H12N4: C 65.6
Table 1
Crystallographic data for compounds [Pd(1)Cl2], [Cu(1)Cl2]2, and [Cu(6)Cl].
[Pd(1)Cl2]
[Cu(1)Cl2]2
[Cu(6)Cl]
Empirical formula
Formula weight
Crystal system
Space group
a (Å)
C6H9Cl2N3Pd
300.46
monoclinic
C2/c
16.175(1)
8.8970(5)
13.0950(8)
90
C12H18Cl4Cu2N6
515.20
C14H14ClCuN3O2
355.27
monoclinic
P21/n
triclinic
ꢀ
P1
6.456(5)
9.011(7)
9.022(8)
65.54(2)
6.636(1)
b (Å)
c (Å)
17.981(4)
11.492(2)
90
a
(°)
b (°)
98.542(1)
90
1863.5(2)
8
2.142
2.511
84.13(3)
72.48(2)
455.4(7)
1
1.878
2.929
98.31(3)
90
1356.8(5)
4
1.739
c
(°)
V (Å3)
Z
qcalc (g cm–3
)
l
(Mo K
a
) (mmꢀ1
)
1.813
Crystal size (mm)
Temperature (K)
hmin, hmax (°)
Dataset
Total unique data
0.70 ꢂ 0.30 ꢂ 0.20
0.25 ꢂ 0.17 ꢂ 0.08
0.66 ꢂ 0.32 ꢂ 0.08
153(2)
153(2)
153(2)
2.79, 30.0
ꢀ22:22, ꢀ12:12, ꢀ15:18
7950, 2706
2508
2706, 110
0.0206, 0.0500, 1.077
0.57, ꢀ0.45
2.48, 27.7
ꢀ8:8, ꢀ11:11, ꢀ11:11
5742, 2129
2011
2129, 116
0.0226, 0.0617, 1.117
0.33, ꢀ0.39
2.17, 32.6
ꢀ10:10, ꢀ27:27, ꢀ17:17
33500, 5269
2767
5269, 192
0.0274, 0.0487, 0.625
0.40, ꢀ0.39
Observed data [I > 2
Nref, Npar
r(I)]
a
R, wR2, S [I > 2
r(I)]
Minimum and maximum residual density (e Åꢀ3
)
P
P
P
P
a
R1
=
||Fo| ꢀ |Fc||/ ||Fo|, wR2 = [ w(F2o ꢀ F2c)2/ w(Fo2)2]1/2
.